Engaging Early: FDA’s Collaborative Pathways for AI in Regulatory Applications (Part 3 of 3)
Blog Post

Engaging Early: FDA’s Collaborative Pathways for AI in Regulatory Applications (Part 3 of 3)

Nick Armstrong, Senior Director of Digital Enablement at CAI and co-chair of the ISPE Community of Practice on AI, specializes in the intersection of artificial...

Read More
A Framework for Trust: Understanding the FDA’s AI Risk-Based Credibility Assessment (Part 1 of 3) 
Blog Post

A Framework for Trust: Understanding the FDA’s AI Risk-Based Credibility Assessment (Part 1 of 3) 

Nick Armstrong, Senior Director of Digital Enablement at CAI and co-chair of the ISPE Community of Practice on AI, specializes in the intersection of artificial...

Read More